| Groups | P value | |
---|---|---|---|
Matched control (n = 28) | Type 2 diabetes (n = 35) | ||
Age (year) | 50.25 ± 13.49 | 50.31 ± 13.43 | 0.985 |
Sex (male/female) | 16/12 | 21/14 | 0.819 |
BMI (kg/m2) | 24.63 ± 2.88 | 25.67 ± 3.10 | 0.178 |
TC (mmol/L) | 4.84 ± 0.99 | 4.80 ± 0.92 | 0.880 |
LDL-C (mmol/L) | 2.92 ± 1.01 | 3.04 ± 0.94 | 0.660 |
HDL-C (mmol/L) | 1.32 ± 0.37 | 1.15 ± 0.26 | 0.042* |
TG (mmol/L) | 1.44 (0.89, 2.14) | 1.80 (1.24, 2.27) | 0.148 |
FBG (mmol/L) | 5.00 ± 0.61 | 8.67 ± 1.47 | <  0.001* |
FINS (μIU/mL) | 8.00 (5.10, 13.25) | 10.20 (6.70, 13.10) | 0.316 |
HbA1c (%) | 5.64 ± 0.47 | 8.04 ± 0.74 | <  0.001* |
HOMA-IR | 1.76 (1.10, 2.99) | 4.19 (2.21, 5.56) | <  0.001* |
HOMA-β | 120.55 (77.38, 165.15) | 41.23 (22.83, 58.26) | <  0.001* |
Adropin (ng/mL) | 5.90 ± 1.22 | 3.12 ± 0.73 | <  0.001* |